Spyre Therapeutics Inc (SYRE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 90,592 | 235,358 | 35,243 | 34,863 | 38,989 |
| Marketable Securities | 113,007 | 0 | 3,235 | 20,848 | 34,687 |
| Receivables | 163 | 1,646 | 330 | 375 | 669 |
| TOTAL | $205,949 | $239,886 | $44,375 | $62,258 | $82,219 |
| Non-Current Assets | |||||
| PPE Net | 0 | 0 | 3,424 | 3,220 | 3,555 |
| Other Non-Current Assets | 1,316 | 3,643 | 4,654 | 5,666 | 5,792 |
| TOTAL | $1,316 | $3,643 | $8,078 | $8,886 | $9,347 |
| Total Assets | $207,265 | $243,529 | $52,453 | $71,144 | $91,566 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 21,501 | 23,664 | 2,062 | 677 | 4,178 |
| Accrued Expenses | 15,861 | 28,427 | 9,665 | 12,837 | 12,408 |
| Other current liabilities | 7,510 | 174,882 | N/A | N/A | N/A |
| TOTAL | $44,872 | $232,234 | $12,637 | $14,656 | $17,678 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | 930 | 302 | 517 | 505 |
| Other Non-Current Liabilities | 407,795 | 216,323 | 3,823 | 4,004 | 4,159 |
| TOTAL | $407,795 | $218,664 | $6,164 | $6,183 | $6,333 |
| Total Liabilities | $452,667 | $450,898 | $18,801 | $20,839 | $24,011 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 4,049 | 4,048 | 2,616 | 2,616 | 2,460 |
| Common Shares | 7 | 6 | 6 | 6 | 6 |
| Retained earnings | -701,234 | -661,127 | -444,046 | -425,624 | -406,802 |
| Other shareholders' equity | -132 | 11 | -6 | -48 | -184 |
| TOTAL | $-245,402 | $-207,369 | $33,652 | $50,305 | $67,555 |
| Total Liabilities And Equity | $207,265 | $243,529 | $52,453 | $71,144 | $91,566 |